Diet Intervention, Head and Neck Cancer, Feasibility
Improving Dietary Patterns in Head and Neck Cancer Survivors to Optimize Disease Outcomes and Supportive Care: A Pilot/Feasibility Intervention Study
1 other identifier
interventional
23
0 countries
N/A
Brief Summary
This study will examine the effects of a dietary intervention in post-treatment head and neck cancer survivors on the ability to function physically, tiredness, and quality of life, as well as on changing markers in the blood that are associated with better recurrence and survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable head-and-neck-cancer
Started Jan 2015
Shorter than P25 for not_applicable head-and-neck-cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 3, 2017
CompletedFirst Posted
Study publicly available on registry
January 6, 2017
CompletedJanuary 6, 2017
January 1, 2017
1.7 years
January 3, 2017
January 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Number of patients excluded or not agreeing to participate
Feasibility measure
Baseline
Adherence to study protocol activities (research records and diet intake self-report)
Feasibility measure (e.g., percent of assessments completed, percent of counseling phone calls completed, servings of cruciferous vegetables eaten, etc.)
Throughout 12 week study period
Attrition rates
Feasibility measure
Throughout 12 week study period
Adverse events with reporting according to institutional review board policy
Throughout 12 week study period
Questionnaire
Participant satisfaction
At conclusion of 12 week study period
Questionnaire
Intervention preferences
At conclusion of 12 week study period
Secondary Outcomes (5)
DNA methylation
At beginning and end of 12 week study period
Serum cytokines
At beginning and end of 12 week study period
Quality of life (assessed using the Functional Assessment of Cancer Therapy Head and Neck index)
At beginning and end of 12 week study period
Total energy and nutrient intakes
At beginning and end of 12 week study period
Covariates
At beginning of 12 week study period
Study Arms (2)
Usual Dietary Care
ACTIVE COMPARATORParticipants receive standard educational materials that focus on healthy eating for cancer survivors and the opportunity to briefly discuss nutrition-related concerns with the Registered Dietitian weekly.
Cruciferous and Dark Leafy Green Intervention
EXPERIMENTALParticipants receive individual dietary counseling from a Registered Dietitian who will focus on increasing intake of cruciferous and green leafy vegetables while addressing any disease- and treatment-related eating difficulties experienced by the participant.
Interventions
Participants receive individual dietary counseling from a Registered Dietitian who will focus on increasing intake of cruciferous and green leafy vegetables while addressing any disease- and treatment-related eating difficulties experienced by the participant.
Participants receive standard educational materials that focus on healthy eating for cancer survivors and the opportunity to briefly discuss nutrition-related concerns with the Registered Dietitian weekly.
Eligibility Criteria
You may qualify if:
- Patients will be eligible to participate if they are 1) diagnosed with Stage I - IV oral, hypopharyngeal, nasopharyngeal, oropharyngeal, or laryngeal cancer; 2) age 19+; 3) at least 6 months - 2 years post-treatment; 4) able to consume foods orally; 5) no evidence of disease; 6) English-speaking
You may not qualify if:
- Patients will not be eligible to participate if they have 1) dementia or organic brain syndrome; 2) severe emotional distress; 3) active schizophrenia; 3) another diagnosis of cancer in the past five years (not including skin or cervical cancer in situ)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Q. Rogers, MD
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 3, 2017
First Posted
January 6, 2017
Study Start
January 1, 2015
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
January 6, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share